Tandem Diabetes Care, Inc.
Panjang
Telah dikemas kini

Bullish outlook for T-Slim X2 Basal-IQ tech

277
TNDM was once a $300 stock, struggled on sales and debt. At the time, they did not have the supreme product and it crashed. Compare to PODD Omnipod that only has bolus and you have to manually suspend, you would want to be with t-slim if you are a diabetic patient. T-slim x2 is marketed globally, sales are up on Q2. Expecting a BIG Q3 from these guys. Pullback? Maybe a little, maybe later, but it's definitely not too late to get in, it's too hot right now. PT $80

+279% 200SMA, +54% 50SMA, +27% 20SMA, Are you sure that you want to be on the other side of the trade?
Dagangan ditutup: sasaran tercapai
Dagangan aktif

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.